Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 4
1994 1
1995 3
1996 3
1997 1
1998 6
1999 2
2000 7
2001 2
2002 5
2003 5
2004 12
2005 2
2006 3
2007 6
2008 7
2009 5
2010 7
2011 4
2012 9
2013 9
2014 7
2015 10
2016 7
2017 5
2018 10
2019 8
2020 11
2021 12
2022 11
2023 4
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.
Exposito F, Redrado M, Serrano D, Calabuig-Fariñas S, Bao-Caamano A, Gallach S, Jantus-Lewintre E, Diaz-Lagares A, Rodriguez-Casanova A, Sandoval J, San Jose-Eneriz E, Garcia J, Redin E, Senent Y, Leon S, Pio R, Lopez R, Oyarzabal J, Pineda-Lucena A, Agirre X, Montuenga LM, Prosper F, Calvo A. Exposito F, et al. Among authors: montuenga lm. Cell Death Dis. 2024 Nov 2;15(11):787. doi: 10.1038/s41419-024-07156-w. Cell Death Dis. 2024. PMID: 39488528 Free PMC article.
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment.
Orive D, Echepare M, Bernasconi-Bisio F, Sanmamed MF, Pineda-Lucena A, de la Calle-Arroyo C, Detterbeck F, Hung RJ, Johansson M, Robbins HA, Seijo LM, Montuenga LM, Valencia K. Orive D, et al. Among authors: montuenga lm. Arch Bronconeumol. 2024 Oct;60 Suppl 2:S67-S76. doi: 10.1016/j.arbres.2024.07.007. Epub 2024 Jul 17. Arch Bronconeumol. 2024. PMID: 39079848 Free article. Review. English, Spanish.
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma.
Patiño-García A, Guruceaga E, Andueza MP, Ocón M, Fodop Sokoudjou JJ, de Villalonga Zornoza N, Alkorta-Aranburu G, Uria IT, Gurpide A, Camps C, Jantus-Lewintre E, Navamuel-Andueza M, Sanmamed MF, Melero I, Elgendy M, Fusco JP, Zulueta JJ, de-Torres JP, Bastarrika G, Seijo L, Pio R, Montuenga LM, Hernáez M, Ochoa I, Perez-Gracia JL. Patiño-García A, et al. Among authors: montuenga lm. EBioMedicine. 2024 Apr;102:105048. doi: 10.1016/j.ebiom.2024.105048. Epub 2024 Mar 13. EBioMedicine. 2024. PMID: 38484556 Free PMC article.
Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers.
Córdoba-Lanús E, Montuenga LM, Domínguez-de-Barros A, Oliva A, Mayato D, Remírez-Sanz A, Gonzalvo F, Celli B, Zulueta JJ, Casanova C. Córdoba-Lanús E, et al. Among authors: montuenga lm. Antioxidants (Basel). 2024 Jan 26;13(2):156. doi: 10.3390/antiox13020156. Antioxidants (Basel). 2024. PMID: 38397754 Free PMC article.
Elevated expression of complement factor I in lung cancer cells associates with shorter survival-Potentially via non-canonical mechanism.
Felberg A, Bieńkowski M, Stokowy T, Myszczyński K, Polakiewicz Z, Kitowska K, Sądej R, Mohlin F, Kuźniewska A, Kowalska D, Stasiłojć G, Jongerius I, Spaapen R, Mesa-Guzman M, Montuenga LM, Blom AM, Pio R, Okrój M. Felberg A, et al. Among authors: montuenga lm. Transl Res. 2024 Jul;269:1-13. doi: 10.1016/j.trsl.2024.02.003. Epub 2024 Feb 22. Transl Res. 2024. PMID: 38395390
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
de-Torres JP, Alcaide AB, Campo A, Zulueta JJ, Bastarrika G, Ezponda A, Mesa M, Murillo D, Rodriguez M, Del Mar Ocón M, Felgueroso C, Pueyo J, Lozano MD, Montuenga LM, Berto J, Perez-Warnisher MT, Di-Frisco IM, Seijo LM. de-Torres JP, et al. Among authors: montuenga lm. Arch Bronconeumol. 2024 Feb;60(2):95-100. doi: 10.1016/j.arbres.2023.12.012. Epub 2024 Jan 3. Arch Bronconeumol. 2024. PMID: 38216404 English, Spanish.
Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (CEA) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
Kiio LK, Onyatta JO, Ndangili PM, Oloo F, Santamaria C, Montuenga LM, Mbui DN. Kiio LK, et al. Among authors: montuenga lm. Talanta. 2024 Jan 1;266(Pt 1):124934. doi: 10.1016/j.talanta.2023.124934. Epub 2023 Jul 13. Talanta. 2024. PMID: 37454512
Circulating proteome for pulmonary nodule malignancy.
Khodayari Moez E, Warkentin MT, Brhane Y, Lam S, Field JK, Liu G, Zulueta JJ, Valencia K, Mesa-Guzman M, Nialet AP, Atkar-Khattra S, Davies MPA, Grant B, Murison K, Montuenga LM, Amos CI, Robbins HA, Johansson M, Hung RJ. Khodayari Moez E, et al. Among authors: montuenga lm. J Natl Cancer Inst. 2023 Sep 7;115(9):1060-1070. doi: 10.1093/jnci/djad122. J Natl Cancer Inst. 2023. PMID: 37369027 Free PMC article.
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response.
Cuttano R, Colangelo T, Guarize J, Dama E, Cocomazzi MP, Mazzarelli F, Melocchi V, Palumbo O, Marino E, Belloni E, Montani F, Vecchi M, Barberis M, Graziano P, Pasquier A, Sanz-Ortega J, Montuenga LM, Carbonelli C, Spaggiari L, Bianchi F. Cuttano R, et al. Among authors: montuenga lm. J Hematol Oncol. 2022 Dec 31;15(1):178. doi: 10.1186/s13045-022-01394-1. J Hematol Oncol. 2022. PMID: 36587234 Free PMC article.
182 results